Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Income towards Parent Company (2016 - 2025)

Rockwell Medical's Income towards Parent Company history spans 16 years, with the latest figure at -$640000.0 for Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 17.84% year-over-year to -$640000.0; the TTM value through Dec 2025 reached -$5.6 million, down 907.4%, while the annual FY2025 figure was -$5.6 million, 907.4% down from the prior year.
  • Income towards Parent Company reached -$640000.0 in Q4 2025 per RMTI's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $1.7 million in Q3 2024 to a low of -$8.9 million in Q4 2021.
  • Average Income towards Parent Company over 5 years is -$3.3 million, with a median of -$2.0 million recorded in 2023.
  • Peak YoY movement for Income towards Parent Company: skyrocketed 179.54% in 2024, then plummeted 632.88% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$8.9 million in 2021, then surged by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then rose by 17.84% to -$640000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Income towards Parent Company are -$640000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.6 million (Q2 2025).